dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Goldstein, David |
dc.contributor.author | Von Hoff, Daniel D. |
dc.contributor.author | Reni, Michele |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Ramanathan, Ramesh K. |
dc.contributor.author | Chiorean, E. Gabriela |
dc.date.accessioned | 2021-10-22T11:49:35Z |
dc.date.available | 2021-10-22T11:49:35Z |
dc.date.issued | 2020-07 |
dc.identifier.citation | Goldstein D, Von Hoff DD, Chiorean EG, Reni M, Tabernero J, Ramanathan RK, et al. Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer. Pancreas. 2020 Jul;49(6):744–750. |
dc.identifier.issn | 1536-4828 |
dc.identifier.uri | https://hdl.handle.net/11351/6454 |
dc.description | Càncer de pàncrees metastàtic; Nomograma; Pronòstic |
dc.description.sponsorship | Writing assistance was provided by John McGuire, PhD, of MediTech Media, Ltd, through funding by Bristol-Myers Squibb Company. The authors are grateful to Abdalla Aly, Marc Botteman, and Julia Wilkerson from Pharmerit International for statistical analysis support through funding by Celgene, a Bristol-Myers Squibb Company. |
dc.language.iso | eng |
dc.publisher | Wolters Kluwer Health |
dc.relation.ispartofseries | Pancreas;49(6) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pàncrees - Càncer |
dc.subject | Nomografia (Matemàtica) |
dc.subject.mesh | Pancreatic Neoplasms |
dc.subject.mesh | Nomograms |
dc.title | Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1097/MPA.0000000000001563 |
dc.subject.decs | neoplasias pancreáticas |
dc.subject.decs | nomogramas |
dc.relation.publishversion | https://doi.org/10.1097/MPA.0000000000001563 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Goldstein D] Department of Medical Oncology, Prince of Wales Hospital, Randwick. Prince of Wales Clinical School, University of New South Wales, New South Wales, Australia. [Von Hoff DD] Division of Molecular Medicine, Translational Genomics Research Institute, Phoenix, AZ. HonorHealth, Scottsdale, AZ. [Chiorean EG] Department of Medicine and Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. [Reni M] Department of Oncology, San Raffaele Scientific Institute, Milan, Italy. [Tabernero J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, CIBERONC, Barcelona, Spain. [Ramanathan RK] Department of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ |
dc.identifier.pmid | 32541630 |
dc.identifier.wos | 000549975300011 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |